Carter, Natalie J <br/><br/>
Besifloxacin ophthalmic suspension 0.6%.  [electronic resource] 

 -  Drugs  2010 
 - 83-97 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.2165/11203820-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Anti-Bacterial Agents--pharmacology<br/>Antifungal Agents--pharmacology<br/>Aza Compounds--pharmacology<br/>Azepines--therapeutic use<br/>Colony Count, Microbial<br/>Conjunctivitis, Bacterial--drug therapy<br/>DNA Gyrase--metabolism<br/>DNA Topoisomerase IV--metabolism<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Eye<br/>Fluoroquinolones--therapeutic use<br/>Humans<br/>Methicillin Resistance<br/>Methicillin-Resistant Staphylococcus aureus<br/>Microbial Sensitivity Tests<br/>Moxifloxacin<br/>Ophthalmic Solutions--therapeutic use<br/>Quinolines--pharmacology<br/>Staphylococcal Infections--drug therapy<br/>Staphylococcus aureus--drug effects<br/>Streptococcus pneumoniae--drug effects<br/>Suspensions--therapeutic use